hippuric acid has been researched along with Kidney Failure, Chronic in 22 studies
hippuric acid: RN given refers to parent cpd; structure in Merck Index, 9th ed, #4591
N-benzoylglycine : An N-acylglycine in which the acyl group is specified as benzoyl.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The uptake of liposomes by direct incubation in vitro showed an obvious dose-response relationship for p-cresyl sulfate (PCS) and indoxyl sulfate (IS) but not for hippuric acid (HA)." | 1.51 | Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis. ( Ding, F; Li, Y; Liu, T; Ma, S; Shi, Y; Tian, H; Wang, W; Wang, Y; Zhu, Q, 2019) |
| "In 8 subjects with chronic renal failure treated conservatively the renal hippurate clearance (CHip), polyfructosan (CPF) and creatinine (Ccr) clearance was assessed." | 1.29 | [Renal clearance of hippurate in persons with chronic renal insufficiency]. ( Dzúrik, R; Nádvorníková, H; Schück, O; Skibová, J; Spustová, V; Teplan, V, 1994) |
| "In haemodialysed patients with chronic renal failure, the plasma levels of HA and FA are elevated in comparison with normal controls and hospital patients without kidney diseases: HA, 11." | 1.28 | Hippuric acid and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid in serum and urine. Analytical approaches and clinical relevance in kidney diseases. ( Bubeck, JI; Liebich, HM; Pickert, A; Scheiter, A; Wahl, G, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (18.18) | 18.7374 |
| 1990's | 6 (27.27) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Deguchi, T | 1 |
| Ohtsuki, S | 1 |
| Otagiri, M | 1 |
| Takanaga, H | 1 |
| Asaba, H | 1 |
| Mori, S | 1 |
| Terasaki, T | 1 |
| Stanimirova, I | 1 |
| Banasik, M | 1 |
| Ząbek, A | 1 |
| Dawiskiba, T | 1 |
| Kościelska-Kasprzak, K | 1 |
| Wojtowicz, W | 1 |
| Krajewska, M | 1 |
| Janczak, D | 1 |
| Młynarz, P | 1 |
| Shafi, T | 2 |
| Sirich, TL | 2 |
| Meyer, TW | 3 |
| Hostetter, TH | 3 |
| Plummer, NS | 2 |
| Hwang, S | 2 |
| Melamed, ML | 2 |
| Banerjee, T | 2 |
| Coresh, J | 2 |
| Powe, NR | 2 |
| Shi, Y | 1 |
| Wang, Y | 1 |
| Ma, S | 1 |
| Liu, T | 1 |
| Tian, H | 1 |
| Zhu, Q | 1 |
| Wang, W | 1 |
| Li, Y | 1 |
| Ding, F | 1 |
| Lin, YT | 1 |
| Wu, PH | 1 |
| Lee, HH | 1 |
| Mubanga, M | 1 |
| Chen, CS | 1 |
| Kuo, MC | 1 |
| Chiu, YW | 1 |
| Kuo, PL | 1 |
| Hwang, SJ | 1 |
| Tsujimoto, M | 1 |
| Nagano, Y | 1 |
| Hosoda, S | 1 |
| Shiraishi, A | 1 |
| Miyoshi, A | 1 |
| Hiraoka, S | 1 |
| Furukubo, T | 1 |
| Izumi, S | 1 |
| Yamakawa, T | 1 |
| Minegaki, T | 1 |
| Nishiguchi, K | 1 |
| Funk, BA | 1 |
| Parekh, RS | 1 |
| Kikuchi, K | 2 |
| Itoh, Y | 2 |
| Tateoka, R | 2 |
| Ezawa, A | 2 |
| Murakami, K | 2 |
| Niwa, T | 3 |
| Nishio, T | 1 |
| Takamura, N | 1 |
| Nishii, R | 1 |
| Tokunaga, J | 1 |
| Yoshimoto, M | 1 |
| Kawai, K | 1 |
| Liebich, HM | 4 |
| Pickert, A | 3 |
| Tetschner, B | 2 |
| Mitch, WE | 1 |
| Brusilow, S | 1 |
| Schück, O | 1 |
| Spustová, V | 3 |
| Dzúrik, R | 3 |
| Teplan, V | 1 |
| Nádvorníková, H | 1 |
| Skibová, J | 1 |
| Lim, CF | 1 |
| Bernard, BF | 1 |
| de Jong, M | 1 |
| Docter, R | 1 |
| Krenning, EP | 1 |
| Hennemann, G | 1 |
| Krivosíková, Z | 1 |
| Gazdíková, K | 1 |
| Krämer, BK | 1 |
| Hohmann, C | 1 |
| Müller, GA | 1 |
| Hablitzel, M | 1 |
| Risler, T | 2 |
| Gajdos, M | 1 |
| Opatrný, K | 1 |
| Stefíková, K | 1 |
| Bubeck, JI | 1 |
| Wahl, G | 1 |
| Scheiter, A | 1 |
| Schoots, AC | 1 |
| De Vries, PM | 1 |
| Thiemann, R | 1 |
| Hazejager, WA | 1 |
| Visser, SL | 1 |
| Oe, PL | 1 |
| Fischer, U | 1 |
| Rapp, K | 1 |
| Eggstein, M | 1 |
1 review available for hippuric acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure.
Topics: Animals; Furans; Hippurates; Humans; Indoles; Kidney Failure, Chronic; Propionates; Protein Binding; | 1996 |
3 trials available for hippuric acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.
Topics: Adult; Aged; Cardiovascular Diseases; Cresols; Female; Glutamine; Hippurates; Humans; Indican; Kidne | 2017 |
Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
Topics: Adult; Aged; Barbiturates; Binding Sites; Carbon Radioisotopes; Diazepam; Diuretics; Fatty Acids, No | 2008 |
In vivo clearance and elimination of nine marker substances during hemofiltration with different membranes.
Topics: Aged; beta 2-Microglobulin; Creatinine; Dialysis Solutions; Hemofiltration; Hippurates; Humans; Kidn | 1992 |
18 other studies available for hippuric acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.
Topics: Animals; Anions; Biological Transport; Dose-Response Relationship, Drug; Female; Furans; Indican; Ki | 2002 |
Serum metabolomics approach to monitor the changes in metabolite profiles following renal transplantation.
Topics: Alanine; Biomarkers; Health Status; Hippurates; Humans; Kidney Failure, Chronic; Kidney Transplantat | 2020 |
Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
Topics: Animals; Cresols; Dialysis Solutions; Equipment Design; Hippurates; Indican; Kidney Failure, Chronic | 2019 |
Indole-3 acetic acid increased risk of impaired cognitive function in patients receiving hemodialysis.
Topics: Aged; Biomarkers; Blood-Brain Barrier; Brain; Capillary Permeability; Cognition; Cognitive Dysfuncti | 2019 |
Effects of decreased vitamin D and accumulated uremic toxin on human CYP3A4 activity in patients with end-stage renal disease.
Topics: Cell Line, Tumor; Cytochrome P-450 CYP3A; Erythromycin; Furans; Hippurates; Humans; Indican; Indolea | 2013 |
Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.
Topics: Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Cresols; Female; Glutamine; Hippurates; H | 2014 |
Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators.
Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Cause of Death; Cresols; Female; Glutamine; Hippur | 2015 |
Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry.
Topics: Animals; Chromatography, Liquid; Cresols; Disease Models, Animal; Hippurates; Humans; Indican; Kidne | 2010 |
Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.
Topics: Adsorption; Animals; Carbon; Chromatography, Liquid; Hippurates; Indican; Kidney Failure, Chronic; M | 2010 |
Gas chromatographic and gas chromatographic-mass spectrometric analysis of organic acids in plasma of patients with chronic renal failure.
Topics: Adolescent; Adult; Aged; Carboxylic Acids; Chromatography, Gas; Female; Furans; Gas Chromatography-M | 1984 |
Benzoate-induced changes in glycine and urea metabolism in patients with chronic renal failure.
Topics: Benzoates; Benzoic Acid; Female; Glomerular Filtration Rate; Glycine; Hippurates; Humans; Kidney Fai | 1982 |
[Renal clearance of hippurate in persons with chronic renal insufficiency].
Topics: Adult; Creatinine; Female; Fructans; Glomerular Filtration Rate; Hippurates; Humans; Kidney; Kidney | 1994 |
A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
Topics: Adsorption; Animals; Biological Transport; Cells, Cultured; Furans; Hippurates; Humans; Indican; Iod | 1993 |
Hippurate participates in the correction of metabolic acidosis.
Topics: Acid-Base Equilibrium; Acidosis; Ammonia; Animals; Glutaminase; Hippurates; Humans; Kidney; Kidney F | 2001 |
Serum hippurate and its excretion in conservatively treated and dialysed patients with chronic renal failure.
Topics: Hippurates; Humans; Kidney Failure, Chronic; Osmolar Concentration; Reference Values; Renal Dialysis | 1991 |
Hippuric acid and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid in serum and urine. Analytical approaches and clinical relevance in kidney diseases.
Topics: Chromatography, Gas; Chromatography, High Pressure Liquid; Furans; Hemofiltration; Hippurates; Human | 1990 |
Biochemical and neurophysiological parameters in hemodialyzed patients with chronic renal failure.
Topics: Calcium; Chromatography, High Pressure Liquid; Hemoglobins; Hippurates; Humans; Kidney Failure, Chro | 1989 |
Gas chromatographic determination of hippuric acid and a furancarboxylic acid in plasma of patients with kidney diseases.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Creatinine; Female; Furans; Hippurates; Humans; Ki | 1987 |